Heterocycles [h]-Fused onto 4-oxoquinoline-3-carboxylic acid, III.1 Facile synthesis and antitumor activity of model heterocycles [a]-fused onto pyrido[2,3-f]quinoxaline-3-carboxylic acids

Heterocycles

Volumn 71, Issue 10, 2007, Pages 2155-2172

  Abu Shuheil, Mohammad Y ^a   Hassuneh, Mona R ^a   Al Hiari, Yusuf M ^a   Qaisi, Ali M ^a   El Abadelah, Mustafa M ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37349126000     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-5414(07)81092-6     Document Type: Article

References (52)

1. Part II :. Al-Huniti M.H., Zahra J.A., and El-Abadelah M.M. Heterocycles 71 (2007) 411
2. Wise R., Andrews J.M., and Edwards L.J. Antimicrob. Agents Chemother. 23 (1983) 559
3. Felmingham D., O'Hare M.D., Robbins M.J., Wall R.A., Williams A.H., Cremer A.W., Ridgeway G.L., and Gruneberg R.N. Drugs Exp. Clin. Res. 11 (1985) 317
4. Maurer F., and Grohe K. Ger. Offen. 3 (1986) 435
5. Maurer F., and Grohe K. Ger. Offen. 3 (1986) 392
6. Maurer F., and Grohe K. Chem. Abstr. 105 (1986) 97158e
7. Petersen U., Bartel S., Bremm K.-D., Himmler T., Krebs A., and Schenke T. Bull. Soc. Chim. Belg. 105 (1996) 683
8. See for example:. Okada T., Ezumi K., Yamakawa M., Sato H., Tsuji T., Tsushima Y., Motokawa K., and Komatsu Y. Chem. Pharm. Bull. 41 (1993) 126
9. Grohe K. Quinolone Antibacterials (1998), Springer-Verlag, Berlin, Heidelberg 13-62
10. Li Q., Mitscher L.A., and Shen L.L. Med. Res. Rev. 20 (2000) 231
11. Zhanel G.G., Ennis K., Vercaigne L., Walkty A., Gin A.S., Embil J., Smith H., and Hoban D.J. Drugs 62 (2002) 13
12. Da Silva A.D., De Almeida M.V., De Souza M.V.N., and Couri M.R.C. Curr. Med. Chem. 10 (2003) 21
13. Daneshtalab M. Topics in Heterocyclic Chemistry. Heterocyclic Antitumor Antibiotics 2 (2005), Springer-Verlag, Berlin/Heidelberg 153-173
14. Elsea H.S., McGuirk P.R., Gootz T.D., Moynihan M., and Osheroff N. Antimicrob. Agents Chemother. 37 (1993) 2179
15. Spitzner J.R., Chung I.K., Gootz T.D., McGuirk P.R., and Muller M.T. Mol. Pharmacol. 48 (1995) 238
16. Riesbeck K., and Forsgren A. Antimicrob. Agents Chemother. 39 (1995) 476
17. Bromberg K.D., Burgin A.B., and Osheroff N. Biochemistry 42 (2003) 3393
18. Yoshinari T., Mano E., Arakawa H., Kurama M., Iguchi T., Nakagawa S., Tanaka N., and Okura A. Jpn. J. Cancer Res. 84 (1993) 800
19. Okura A., Yoshinari T., Arakawa H., Nakagawa S., Mano E., and Ushijima R. PCT Int. Appl. 118 (1992) WO 9212146
20. Okura A., Yoshinari T., Arakawa H., Nakagawa S., Mano E., and Ushijima R. Chem. Abstr. (1993) 147465
21. Arakawa H., Mano E., Hakoda N., Yoshinari T., Nakagawa S., and Okura A. Anti-Cancer Drug Des. 11 (1996) 221
22. Elsea S.H., Westergaard M., Burden D.A., Lomenick J.-P., and Osheroff N. Biochemistry 36 (1997) 2919
23. Kamat A.M., DeHaven J.I., and Lamm D.L. Urology 54 (1999) 56
24. Nishijima C., Kawada K., Ohara K., Shinomiya T., Fukuda S., Nakamura A., Sawai T., and Ikekita M. Res. Comm. Biochem. Cell Mol. Biol. 6 (2002) 21
25. Huang D., Okada K., Komori C., Itoi E., and Suzuki T. Cancer Sci. 95 (2004) 845
26. Cheeseman G.W.H., and Cookson R.F. Condensed Pyrazines. In: Weissberger A., and Taylor E.C. (Eds). The Chemistry of Heterocyclic Compounds 35 (1979), John Wiley & Sons, New York
27. Porter A.E.A. Pyrazines and their benzo derivatives. In: Boulton A.J., and McKillop A. (Eds). Comprehensive Heterocyclic Chemistry 3 (1984), Pergamon Press, Oxford 157-197 and references cited therein
28. Loriga M., Fiore M., Sanna P., and Paglietti G. Farmaco 51 (1996) 559
29. Rodrigo G., Robinsohn A.E., Hedrera M.E., Kogan M., Sicardi S.M., and Fernandez B.M. Trends Heterocycl. Chem. 8 (2002) 137
30. Chicharro R., de Castro S., Reino R.L., and Aran J.V. Eur. J. Org. Chem. (2003) 2314
31. Alvarez M., Salas M., and Joule J.A. Heterocycles 32 (1991) 759
32. Grohe K., and Heitzer H. Liebigs Ann. Chem. (1987) 29
33. Petersen U., Grohe K., Schenke T., Hagemann H., Zeiler H.J., and Metzger K.G. Ger. Offen. 3 (1987) 601
34. Petersen U., Grohe K., Schenke T., Hagemann H., Zeiler H.J., and Metzger K.G. Ger. Offen. 3 (1987) 567
35. Petersen U., Grohe K., Schenke T., Hagemann H., Zeiler H.J., and Metzger K.G. Chem. Abstr. 107 (1987) 236747
36. Pulla R.M., and Venkaiah C.N. PCT Int. Appl. 135 (2001) WO 085 692
37. Pulla R.M., and Venkaiah C.N. Chem. Abstr. (2001) 371649
38. Sanchez J.P., Domagala J.M., Hagen S.E., Heifetz C.L., Hutt M.P., Nichols J.B., and Trehan A.K. J. Med. Chem. 31 (1988) 983
39. Frazer R.R., Petit M.A., and Sanders J.K. J. Chem. Soc., (D): Chem. Connun. (1971) 1450
40. Cockerill A.F., Davis G.L.O., Harden R.C., and Racham D.M. Chem. Rev. 73 (1973) 553
41. Frazer R.R. In: Morrison J.D. (Ed). Asymmetric Synthesis 1 (1983), Academic Press, New York 173
42. Wenzel T.J., and Zaia J. Anal. Chem. 59 (1987) 562
43. Bocci G., Nicolaou K.C., and Kerbel R.S. Cancer Res. 62 (2002) 6938
44. Nakamura J., Purvis E.R., and Swenberg J.A. Nucleic Acids Res. 31 (2003) 61790
45. Souid A., Penefsky H.S., Sadowitz P.D., and Toms B. Mol. Pharm. 3 (2006) 307
46. Hsiao H.-I., Wang W.-S., Chenl P.-M., and Su Y. Carcinogenesis 27 (2006) 936
47. Damiano J.S., Cress A.E., Hazlehurst L.A., Shtil A.A., and Dalton W.S. Blood 93 (1999) 1658
48. Sethi T., Rintoul R.C., Moore S.M., MacKinnon A.C., Salter D., Choo C., Chilvers E.R., Dransfield I., Donnelly S.C., Strieter R., and Haslett C. Nat. Med. 5 (1999) 662
49. Wolff J.E., Pascha K.P., Poppenborg H., Anderson R., Thulig C.C., and Krebs B. Anti- cancer Drugs 9 (1998) 803
50. Tallen G., Mock C., Gangopadhyay S.B., Kangarloo B., Krebs B., and Wolff J.E. Anticancer Res. 20 (2000) 445
51. Gharehbaghi K., Szekeres T., Yalowitz J.A., Fritzer-Szekeres M., Pommier Y.G., and Jayaram H.N. Life Sci. 68 (2000) 1
52. de Longueville F., Lacroix M., Barbuto A.M., Bertholet V., Gallo D., Larsimont D., Marcq L., Zammatteo N., Boffe S., Leclercq G., and Remacle J. Int. J. Oncol. 27 (2005) 881